Low-dose steroid-induced bradyarrhythmias and treatment refractory hypokalaemia: a case report

Cardiol Young. 2021 Apr;31(4):651-653. doi: 10.1017/S1047951120004308. Epub 2020 Dec 3.

Abstract

Corticosteroid therapy has become an important modality of treatment for diseases in which rapid control of immunoinflammatory processes is required. However, one of the serious, but less known adverse effect of this therapy is cardiac arrhythmias. This includes both tachyarrhythmias and bradyarrhythmias. Corticosteroid use may also be associated with electrolyte imbalances like hypokalaemia by its mineralocorticoid activity. Those side effects are mainly seen with high-dose intravenous methyl-prednisolone or oral pulse dose prednisolone therapy. Here we report our experience in a child with warm idiopathic autoimmune haemolytic anaemia who developed sinus bradyarrhythmias and treatment refractory hypokalaemia during low-dose steroid therapy with reduction in heart rate by 60% of baseline.

Keywords: Low-dose steroids; hypokalaemia; sinus bradyarrhythmia; warm idiopathic autoimmune haemolytic anaemia.

Publication types

  • Case Reports

MeSH terms

  • Bradycardia* / chemically induced
  • Child
  • Glucocorticoids
  • Humans
  • Hypokalemia* / chemically induced
  • Methylprednisolone
  • Steroids

Substances

  • Glucocorticoids
  • Steroids
  • Methylprednisolone